(Q38443343)
English
A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-in
scientific article published on 16 October 2013
Statements
1 reference
A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-in (English)
1 reference
Stephen Gardner
1 reference
Amy Cutrell
1 reference
Cindy Elko-Simms
1 reference
Kimberly Adkison
1 reference
Robert Hamatake
1 reference
Jill Walker
1 reference
Maribel Rodriguez-Torres
1 reference
Zhi Hong
1 reference
16 October 2013
1 reference
1 reference
34
1 reference
6
1 reference
e89-95
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference